PEGFILGRASTIM Side Effects

7000948-8 | Cystitis
on Sep 10, 2010 Female patient from UNITED STATES , 66 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Pegfilgrastim (View Usage). Patient experienced the following unwanted or unexpected effects: cystitis. Pegfilgrastim dosage: . During the same period patient was treated with DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), PACLITAXEL (View Paclitaxel Review and Paclitaxel Label ), BEVACIZUMAB (View Bevacizumab Review and Bevacizumab Label ), DITROPAN (View Ditropan Review and Ditropan Label ). Patient was hospitalized.

6943441-0 | Lung Infection, Pneumonia
Patient was taking Pegfilgrastim (View Usage). Patient had the following side effects: lung infection, pneumonia (What is pneumonia?) on Aug 18, 2010 from UNITED STATES Additional patient health information: Male patient , 63 years of age, . Pegfilgrastim dosage: . During the same period patient was treated with BEVACIZUMAB (View Bevacizumab Review and Bevacizumab Label ), DOCETAXEL (View Docetaxel Review and Docetaxel Label ), GEMCITABINE (View Gemcitabine Review and Gemcitabine Label ), NYSTATIN (View Nystatin Review and Nystatin Label ), OXYCODONE HCL (View Oxycodone Hcl Review and Oxycodone Hcl Label ), ESOMEPRAZOLE MAGNESIUM (View Esomeprazole Magnesium Review and Esomeprazole Magnesium Label ), VERAPAMIL (View Verapamil Review and Verapamil Label ), DEXAMETASON (View Dexametason Review and Dexametason Label ). Patient was hospitalized.

6869232-7 | Lung Infection, Pneumonia
Adverse event was reported on Jul 20, 2010 by a Male patient taking Pegfilgrastim (View Usage) (Dosage: ) . Location: UNITED STATES , 63 years of age, After Pegfilgrastim was administered, patient had the following side effects: lung infection, pneumonia (What is pneumonia?). During the same period patient was treated with BEVACIZUMAB (View Bevacizumab Review and Bevacizumab Label ), DOCETAXEL (View Docetaxel Review and Docetaxel Label ), GEMCITABINE HCL (View Gemcitabine Hcl Review and Gemcitabine Hcl Label ), NYSTATIN (View Nystatin Review and Nystatin Label ), OXYCODONE (View Oxycodone Review and Oxycodone Label ), ESOMEPRAZOLE MAGNESIUM (View Esomeprazole Magnesium Review and Esomeprazole Magnesium Label ), VERAPAMIL (View Verapamil Review and Verapamil Label ), DEXAMETASON (View Dexametason Review and Dexametason Label ). Patient was hospitalized.

6396670-1 | Dysphagia, Salivary Hypersecretion, Swollen Tongue
on Oct 02, 2009 Male patient from GERMANY , 67 years of age, was treated with Pegfilgrastim (View Usage). Patient experienced the following unwanted or unexpected effects: dysphagia, salivary hypersecretion, swollen tongue. Pegfilgrastim dosage: . During the same period patient was treated with AZACITIDINE (View Azacitidine Review and Azacitidine Label ).


6396669-5 | Swollen Tongue
on Oct 01, 2009 Male patient from GERMANY , 46 years of age, was treated with Pegfilgrastim (View Usage). Patient had the following side effects: swollen tongue. Pegfilgrastim dosage: . During the same period patient was treated with AZACITIDINE (View Azacitidine Review and Azacitidine Label ).

6215732-2 | Disseminated Intravascular Coagulation
Patient was taking Pegfilgrastim (View Usage). After Pegfilgrastim was administered, patient had the following side effects: disseminated intravascular coagulation on Jun 02, 2009 from HUNGARY Additional patient health information: Male patient , weighting 174.2 lb, was diagnosed with gastric cancer and. Pegfilgrastim dosage: . During the same period patient was treated with FUROSEMIDE (View Furosemide Review and Furosemide Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), DOCETAXEL (View Docetaxel Review and Docetaxel Label ), OXALIPLATIN (View Oxaliplatin Review and Oxaliplatin Label ), FERRUM + FOLIC ACID (View Ferrum + Folic Acid Review and Ferrum + Folic Acid Label ), METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ).

6207031-X | Disseminated Intravascular Coagulation
Adverse event was reported on May 21, 2009 by a Male patient taking Pegfilgrastim (View Usage) (Dosage: ) was diagnosed with gastric cancer and. Location: HUNGARY , weighting 174.2 lb, Patient experienced the following unwanted or unexpected effects: disseminated intravascular coagulation. During the same period patient was treated with FUROSEMIDE (View Furosemide Review and Furosemide Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), DOCETAXEL (View Docetaxel Review and Docetaxel Label ), OXALIPLATIN (View Oxaliplatin Review and Oxaliplatin Label ), FERRUM + FOLIC ACID (View Ferrum + Folic Acid Review and Ferrum + Folic Acid Label ), METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ).

4632109-1 | Cardiac Arrest, Circulatory Collapse, Cold Sweat, Diarrhoea, Hallucination, Headache, Hepatomegaly, Infection, Melaena
on Oct 28, 2002 Female patient from , weighting 116.0 lb, was treated with Pegfilgrastim (View Usage). Patient had the following side effects: cardiac arrest (What is cardiac arrest?), circulatory collapse, cold sweat, diarrhoea, hallucination, headache (What is headache?), hepatomegaly, infection (What is infection?), melaena. Pegfilgrastim dosage: . During the same period patient was treated with BRUFEN (View Brufen Review and Brufen Label ), DOMPERIDONE (View Domperidone Review and Domperidone Label ). Patient was hospitalized.